BTC swings about 8% in hours after Iran strikes, stays on a 5‑month losing streak as Hayes ties prolonged conflict to future Fed easing. BitMEX co-founder ArthurBTC swings about 8% in hours after Iran strikes, stays on a 5‑month losing streak as Hayes ties prolonged conflict to future Fed easing. BitMEX co-founder Arthur

Arthur Hayes eyes Fed easing bid as Iran strikes continue to echo into crypto markets

2026/03/02 17:13
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

BTC swings about 8% in hours after Iran strikes, stays on a 5‑month losing streak as Hayes ties prolonged conflict to future Fed easing.

Summary
  • BTC slid from roughly $68k toward $63k on Feb. 28 airstrikes, then rebounded near $68k after reports of Khamenei’s death, an intraday swing of about 8%.
  • BTC is on track for a 5th consecutive monthly loss, its longest red streak since 2018, with February down about 14–15% and price nearly 48% off the $126k peak.
  • Hayes argues every major US Middle East campaign since 1985 has been followed by Fed easing; he plans to scale into BTC only after clear rate cuts or renewed QE.

BitMEX co-founder Arthur Hayes published an analysis on March 1 examining potential connections between U.S. military involvement in Iran and cryptocurrency markets, according to his essay.

Hayes outlined what he characterized as a four-decade pattern of U.S. intervention in the Middle East followed by Federal Reserve monetary easing. The analysis suggested that extended U.S. engagement in conflict could increase the probability of Fed rate cuts or expanded money supply to finance military operations, which Hayes projected could affect Bitcoin prices.

The essay referenced historical precedents, including the 1990 Gulf War, when Federal Open Market Committee minutes from August of that year stated that “events in the Middle East had greatly complicated the formulation of an effective monetary policy,” preceding rate cuts later that year. Hayes also cited the Federal Reserve’s emergency meeting following the September 11, 2001 attacks, when then-Chair Alan Greenspan reduced rates by 50 basis points, referencing a “heightened degree of fear and uncertainty” affecting asset prices.

Cryptocurrency markets responded to recent geopolitical developments during weekend trading hours when traditional financial markets were closed. Bitcoin declined sharply within minutes of initial reports of strikes on February 28, according to market data. The asset subsequently reversed direction following reports regarding Iranian Supreme Leader Ayatollah Ali Khamenei’s death.

Hayes’ analysis noted that every U.S. president since 1985 has conducted military operations in the Middle East, with subsequent financial impacts addressed through monetary policy adjustments.

“The longer Trump engages in the extremely costly activity of Iranian nation-building, the higher the likelihood the Fed lowers the price and increases the quantity of money to support Pax Americana’s latest bout of Middle Eastern adventurism,” Hayes wrote in the essay.

Bitcoin has recorded five consecutive months of losses, a streak last observed in 2018, according to market data.

Hayes recommended a cautious trading approach given uncertainty regarding the duration of U.S. engagement and market tolerance levels. The former BitMEX CEO suggested that optimal purchasing opportunities for Bitcoin and other cryptocurrency assets would occur after the Federal Reserve implements rate cuts or resumes quantitative easing measures to support government objectives in Iran, rather than during initial conflict periods.

Market Opportunity
Echo Logo
Echo Price(ECHO)
$0.016643
$0.016643$0.016643
+0.56%
USD
Echo (ECHO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09